Stock FBIOP FORTRESS BIOTECH, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Consensus Fortress Biotech, Inc. Nasdaq

Equities

FBIOP

US34960Q2084

Market Closed - Nasdaq
Other stock markets
 21:00:00 17/05/2024 BST 		5-day change 1st Jan Change
16.67 USD +1.96% Intraday chart for Fortress Biotech, Inc. +4.32% +40.44%
05-15 Earnings Flash (FBIO) FORTRESS BIOTECH Posts Q1 Revenue $13M MT
05-14 Fortress Biotech Says First Patient Dosed in Phase 2 Study of Triplex MT

Evolution of the average Target Price on Fortress Biotech, Inc.

Price target over the last 5 years

History of analyst recommendation changes

8dc13604865b166afed663bea95f.e8QrZYUUXtQMIx0LHdzqU5WFvh2paepp7cQJLcSgyR4.Lf0GAb1Oa45NQnJEWLu8Bc3K_UfkHoA-v5Q7XK3D-1cujGMGsWQVvGV7fg~742581277b1c150b0b19e57698b07b04

Analyst Recommendations on Fortress Biotech, Inc.

Alliance Global Partners Initiates Fortress Biotech at Buy Rating With $5 Price Target MT
Roth MKM Lowers Price Target on Fortress Biotech to $15 From $30, Maintains Buy Rating MT
B. Riley Trims Fortress Biotech's Price Target to $4 From $6, Keeps Buy Rating MT
Cantor Fitzgerald Lowers Price Target on Fortress Biotech to $5 From $6, Maintains Overweight Rating MT
Ladenburg Thalmann Starts Fortress Biotech at Buy With $6 Price Target MT
B. Riley Securities Lowers Fortress Biotech's Price Target to $6 from $8, Keeps Buy Rating MT
Benchmark Capital Adjusts Fortress Biotech's Price Target to $5 from $8, Keeps Buy Rating MT
FORTRESS BIOTECH : B. Riley Lowers Fortress Biotech's PT to $8 from $9, Says Incremental Pipeline Updates Suggest Heightened Focus on Next-Gen Therapies; Keeps Buy Rating MT
FORTRESS BIOTECH : Roth Capital Adjusts Price Target on Fortress Biotech to $5 From $4.50, Maintains Buy Rating MT
FORTRESS BIOTECH : B. Riley Raises Fortress Biotech's Price Target to $9 from $8 After 'Strong' Q4 2020 Results, Keeps Buy Rating MT
Avenue Therapeutics : Biotech incubator taps investors through in-house brokerage RE
More recommendations

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
5
Last Close Price
1.93 USD
Average target price
10.75 USD
Spread / Average Target
+456.99%
High Price Target
24 USD
Spread / Highest target
+1,143.52%
Low Price Target
4 USD
Spread / Lowest Target
+107.25%

Consensus detail

Consensus revision (last 18 months)

Analysts covering Fortress Biotech, Inc.

Alliance Global Partners
Roth MKM
B. Riley
Cantor Fitzgerald
Ladenburg Thalmann
Benchmark Capital

Ratings for Fortress Biotech, Inc.

Trading Rating
Investor Rating
ESG Refinitiv
More Ratings

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar
  1. Stock Market
  2. Equities
  3. FBIO Stock
  4. FBIOP Stock
  5. Consensus Fortress Biotech, Inc.